MAR 15, 2018 11:18 AM PDT

Algorithm Predicts Glioma Survival Better Than Specialists

WRITTEN BY: Kara Marker

For people newly diagnosed with glioma, a lethal brain cancer, the most they can hope for is an accurate diagnosis, so doctors can choose the best treatment plan, and a careful prognosis, so they can plan for their future. New technology from Emory University provides an option to produce both.

Pathology specimen of a glioma of the midline. Credit: Jensflorian

Glioma is characterized by any tumor that develops from the supportive tissue of the brain, called glia, which regulates neuron function. Symptoms and treatment depend on the exact type of glial cell that is affected by cancer, and the exact cause of glioma is unknown. Doctors do know that those diagnosed with glioma often die within two years of diagnosis, but some people survive for more than a decade. How can doctors distinguish between the two groups so glioma patients know how to plan for their future?

Existing options for glioma diagnosis and prognosis include genomic tests and microscopic examinations of tissue samples. However, genetic testing cannot predict a patient’s future on its own, and microscopic exams are open to interpretation by different doctors.

"Genomics have significantly improved how we diagnose and treat gliomas, but microscopic examination remains subjective,” explained lead scientist Daniel J. Brat, MD, PhD. “There are large opportunities for more systematic and clinically meaningful data extraction using computational approaches.”

The opportunity seized by Emory scientists focused on artificial intelligence (AI) software designed to predict which glioma patients will survive longer than a couple of years. The program is based on tissue biopsies. And so far, the software has been more accurate than predictions made by glioma specialists.

Microscopic images of brain tumor tissue samples and a process called “deep-learning” were used to program software to act as glioma specialists, looking for visual clues that indicate a patient’s odds of survival. Researchers primed the software with both images and genomic data.

After testing the software, its predictions of how long glioma patients survived following their diagnoses was more accurate than predictions made by human pathologists. Over time, the software “learns to recognize many of the same structures and patterns in the tissues that pathologists use when performing exams.”

Scientists want to see this program making predictions for doctors seeing glioma patients. This could greatly enhance decision making about treatments and future planning. Researchers are also looking for new opportunities to further test the program’s ability to improve outcomes for patients newly diagnosed with glioma.

"What the pathologists do with a microscope is amazing. That an algorithm can learn a complex skill like this was an unexpected result,” said lead author Lee A.D. Cooper, PhD. “This is more evidence that AI will have a profound impact in medicine, and we may experience this sooner than expected."

The present study was published in the journal Proceedings of the National Academy of Sciences.

Sources: American Brain Tumor Association, Emory Health Sciences

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog:
You May Also Like
DEC 06, 2019
Health & Medicine
DEC 06, 2019
In Vivo Tissue Stem Cell and Progenitor Cell Genome Modification
A stem cell, by definition, must be able to self-replicate to make more stem cells and to differentiate into a mature cell type. They can be unipotent...
DEC 06, 2019
Cell & Molecular Biology
DEC 06, 2019
Researchers Discover Molecule That May Cause Lyme Disease Symptoms
Scientists at Virginia Tech have found a molecule that can potentially improve the diagnosis and treatment of Lyme disease....
DEC 06, 2019
Genetics & Genomics
DEC 06, 2019
Risk Factors for Gout Revealed by Genome-Wide Association Study
Gout is a common type of arthritis, and causes severe and sudden pain, redness and swelling in the joints....
DEC 06, 2019
Clinical & Molecular DX
DEC 06, 2019
Patients can Self-Inject Easily Using an Integrated Pre-Filled Syringe and Autoinjector
The patients suffering from chronic disease require a regular dose of medicines, either orally or as injections. To prevent a monthly visit...
DEC 06, 2019
Health & Medicine
DEC 06, 2019
Sherlock's DNA biosensors set to make diagnostics elementary
The anxious wait to receive results from expensive diagnostic laboratory tests could soon be a thing of the past thanks to a technological breakthrough. En...
DEC 06, 2019
DEC 06, 2019
Predicting Death with Clinical Immune Indicators
Immune and inflammation status could help doctors predict which individuals are most at-risk for death. Results from a new study mark the first step toward...
Loading Comments...